The expression of CPT1A, CPT1B, and ACAD9 was elevated in recurrent gliomas compared to primary tumors, whereas there was no difference in the expression of VLCAD and SCAD between primary and recurrent GBM. This evidence concerns the gene CPT1B and glioblastoma.